Crossmark

An evidence update to explore molecular targets and protective mechanisms of apigenin against abdominal aortic aneurysms based on network pharmacology and experimental validation

Crossref DOI link: https://doi.org/10.1007/s11030-023-10723-6

Published Online: 2023-08-31

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Dongyu

Wang, Lei

Jiang, Bo

Miao, Yuxi

Li, Xuan
License Information

Text and Data Mining valid from 2023-08-31

Version of Record valid from 2023-08-31
More Information

Article History

Received: 15 June 2023

Accepted: 23 August 2023

First Online: 31 August 2023

Declarations

:

: All authors declare no competing interests are involved in this study.

: The animal procedures in this research were approved by the Ethics Committee of China Medical University (Ethic Number: KT2022498). All applicable institutional and governmental regulations concerning the ethical use of animals were followed.

Document is current

Any future updates will be listed below